ClinicalTrials.gg
Status unknownNCT03348605Updated Nov 21, 2017

Descriptive Study of Receptive Fields in Lower Limb Amputees

An interventional study of Phantom Stimulator, Cort X Sensorics, Spaichingen, Germany in Lower Limb Amputation Below Knee (Injury), sponsored by Rehaklinik Bellikon. Status unknown at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-21.

Sponsored by Rehaklinik Bellikon · Not applicable, Interventional, and Screening

The sponsor has not verified this record recently (last verified Nov 2017), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

It has been observed that patients subjected to amputations develop so called receptive fields, which time of occurrence and localization over time are yet not examined systematically.

This clinical trial aims to investigate the reliability in detecting these receptive fields as well as their incidence and changes over time.

Further it aims to evaluate the acute effect of a stimulating system ("Phantom Stimulator" (Cort X Sensorics, Spaichingen, Germany)) on selected gait parameters measured tough a gait analysis system ("OprtoGait" (Microgate, Bolzano, Italy)) as well as on phantom sensations measured through a questionnaire.

Read the detailed description

It has been observed that patients subjected to amputations develop so called receptive fields, which time of occurrence and localization over time are yet not examined systematically.

A receptive field is defined as skin area anywhere on the same side of the body as the amputation, which when stimulated by others, causes phantom sensations in the amputated extremity.

This clinical trial aims to investigate the reliability in detecting these receptive fields as well as their incidence and changes over time.

Further it aims to evaluate the acute effect of the stimulating system ("Phantom Stimulator" (Cort X Sensorics, Spaichingen, Germany)) on selected gait parameters measured tough a gait analysis system ("OprtoGait" (Microgate, Bolzano, Italy)) as well as on phantom sensations measured through a questionnaire.

02

Conditions studied

  • Lower Limb Amputation Below Knee (Injury)

Keywords

  • Amputation
  • Phantom Pain
  • Gait analysis
03

In context

Wounds and Injuries

2,217 studies on the registry are indexed under Wounds and Injuries; 441 are open to participants now.

This study's planned enrollment of 35 is below the median of 70 across 1,424 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

This is the only study on the registry with Rehaklinik Bellikon as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

  1. Inclusion criteria for descriptive study:

    a. Lower limb amputation (independently of side or height of amputation)

  2. Inclusion criteria for Phantom stimulator:

    1. Receptive fields present at testing day 31 (last regular assessment of the receptive fields)
    2. Lower limb amputation below the knee (if both sides the system is applied to the dominant side).
  3. Exclusion criteria:

    1. Implanted devices (defibrillator or pacemaker)
    2. Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
35 participants (estimated)

Study arms

  • Other
    First setting ON

    This arm performs the Gait analysis the first time after the familiarization phase with the stimulator in the modality ON. The second time the gait analysis is performed in the OFF modality.

    Device: Phantom Stimulator, Cort X Sensorics, Spaichingen, Germany

  • Other
    First setting OFF

    This arm performs the Gait analysis the first time after the familiarization phase with the stimulator in the modality OFF. The second time the gait analysis is performed in the ON modality.

    Device: Phantom Stimulator, Cort X Sensorics, Spaichingen, Germany

Interventions

  • DevicePhantom Stimulator, Cort X Sensorics, Spaichingen, Germany

    This system consists of a pressure sensing insole connected to regular TENS-Electrode patches which are applied to the receptive fields of the patients (evoking the sensation of heel and forefoot). The individually adjusted stimulation intensity on the systems regulatory box through a socked screw is set at the beginning of the testing phase, and not changed anymore. The current is applied to mimic the roll-off-sensation while walking. This is done by locating two sets of electrodes on the receptive fields representing the heel and the ball of the foot respectively. Now the current is applied in an alternating manner coordinated with the walking of the participant. The coordination is made able through the pressure sensing insole.

06

What researchers measure

Primary outcomes

  1. Description of receptive Fields Size in cm2

    The primary outcomes are the changes in size over time. Here the size is described in cm2. The Fields size will be recorded by drawing them on the skin with eyeliner and subsequently taking photos. Later, these photos are analysed with the computer program Photoshop.

    Time frame: 4-5 Weeks (7 hours)

  2. Description of receptive Fields Position in % overlapping from first measurement

    The primary outcomes are the changes in Position over time. Here the position is described in % overlapping with respect to the first measurement. The Fields position will be recorded by drawing them on the skin with eyeliner and subsequently taking photos. Later, these photos are put together and compared with the computer program Photoshop.

    Time frame: 4-5 Weeks (7 hours)

Secondary outcomes

  1. Change in gait parameters through Phantom Stimulator

    The secondary outcomes are the change in selected gait parameters through the application of the stimulating system ("Phantom Stimulator" (Cort X Sensorics, Spaichingen, Germany)). These parameters are measured with the gait analysis system Optogait. The selected parameters are step length (cm), width (cm), cadence (steps/min) and speed (m/s).

    Time frame: 1/2 Day (3 hours)

  2. Change in phantom sensations through Phantom Stimulator

    The secondary outcomes are the change in phantom sensations through the application of the stimulating system ("Phantom Stimulator" (Cort X Sensorics, Spaichingen, Germany)). These changes are measured through a questionnaire witch uses the Visual Analogue Scale (values from 1 - 10).

    Time frame: 1/2 Day (3 hours)

07

Study locations

1 site
  • Rehaklinik Bellikon
    Bellikon, Aargau 5454, Switzerland
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — IPD is used only internally the study concerning the Phantom Stimulator (Cort X Sensorics, Spaichingen Germany). The IPD is shared with the responsible investigative parties of the Rehaklinik Bellikon only. It will be available to the participant after completion of the study. The data obtained from the Study results in a publication after completion of the study.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03348605
Lead sponsor
Rehaklinik Bellikon
Collaborators
Cort X Sensorics GmbH
Responsible party
Sponsor
First posted
Nov 21, 2017
Start date
Oct 27, 2017
Primary completion
Jun 2018 (estimated)
Completion
Jul 2018 (estimated)
Last update
Nov 21, 2017

Study contacts

Marion Grögli, Dr. med.
principal investigator · Reahklinik Bellikon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion